Integrative Oncology Research Training Program at MSKCC

描述（由申请人提供）：MSKCC的综合肿瘤学研究培训计划旨在促进肿瘤学专业人员在补充疗法和植物药物方面的高质量科学研究。我们将培养博士后（医学博士和/或医学博士/博士）在补充疗法，转化和临床研究，包括症状控制，治疗，如针灸，以及实验室和临床研究的植物药物。学员将参加临床和研究会议，并将接受综合肿瘤学研究各方面的多学科指导：方法论；道德规范;生物统计学;人体实验，辅助疗法和植物疗法等。申请4个职位，前3年2个，后3年2个，在这个5年项目的第三年有一年重叠。受训者将完成内科、普通外科、肿瘤医学或家庭实践等医学或外科学科的初步培训。选定的学员将致力于肿瘤学补充疗法或植物药物的科学研究。他们将接受培训，使用证据将有用的补充疗法整合到主流实践和研究中。一个多学科的教师将在这些疗法的研究和应用方面提供指导和丰富的经验。导师包括来自综合医学、放射肿瘤学、内科肿瘤学、外科肿瘤学、流行病学和生物统计学、神经病学、儿科、老年病学、放射学、物理医学和康复服务的高级MSKCC调查员。研究将包括对植物药物的实验室研究以及治疗乳腺癌、肺癌、头颈癌和其他患者群体的疼痛、潮热、疲劳和其他症状的补充方式。由现有的K-30奖资助的临床调查核心临床研究方法论课程将提供临床试验设计和实施的说教式教学。我们的P50植物免疫调节剂研究中心为实验室和临床植物药物研究提供了一个结构。研究人员将把获得的知识应用于综合肿瘤学研究的设计、实施和出版。这个培训项目将帮助被录取的研究员成为独立的研究者，让主流肿瘤学研究人员了解综合肿瘤学，并希望在这个重要的领域得到进一步发展。

DESCRIPTION (provided by applicant): The Integrative Oncology Research Training Program at MSKCC aims to further high-quality scientific research in complementary therapies and botanicals among oncology professionals. We will train post- doctoral (MD and/or MD/PhD) fellows in complementary therapies translational and clinical research, including symptom control, with therapies such as acupuncture, as well as lab and clinical investigation of botanical agents. Trainees will attend clinical and research conferences and will receive multidisciplinary instruction in all facets of Integrative Oncology research: methodology; ethics; biostatistics; human subjects, complementary therapies and botanicals, etc. Four positions are requested, two for the first 3 years and two for the last 3, with one-year overlap during year 3 of this 5-year program. Trainees will have completed initial training in a medical or surgical discipline such as Internal Medicine, General Surgery, Medical Oncology or Family Practice. Selected trainees will be committed to the conduct of scientific research in complementary therapies or botanicals in oncology. They will be trained to use evidence to integrate useful complementary therapies into mainstream practice and research. A multidisciplinary faculty will mentor and enable rich experience in the study and application of these therapies. Preceptors include senior MSKCC investigators from the Integrative Medicine, Radiation Oncology, Medical Oncology, Surgical Oncology, Epidemiology and Biostatistics, Neurology, Pediatrics, Geriatrics, Radiology, and Physical Medicine and Rehabilitation Services. Research will include laboratory studies of botanicals as well as complementary modalities for the management of pain, hot flashes, fatigue and other symptoms in breast, lung, head and neck cancer and other patient groups. A core Clinical Research Methodology curriculum in clinical investigation, funded by an existing K-30 Award, will provide didactic teaching in the design and conduct of clinical trials. Our P50 Research Center for Botanical Immunomodulators provides a structure for laboratory and clinical botanicals research. Research Fellows will apply knowledge gained to the design, implementation and publication of studies in Integrative Oncology. This training program will help accepted fellows become independent investigators, expose mainstream oncology researchers to Integrative Oncology, and hopefully further this important field in general.